» Articles » PMID: 30795787

CircSETD3 (Hsa_circ_0000567) Acts As a Sponge for MicroRNA-421 Inhibiting Hepatocellular Carcinoma Growth

Overview
Publisher Biomed Central
Specialty Oncology
Date 2019 Feb 24
PMID 30795787
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNAs (circRNAs) play important roles in tumourigenesis and tumour progression. However, the expression profiles and functions of circRNAs in hepatocellular carcinoma (HCC) are largely unclear.

Methods: The expression profiles of circRNAs in HCC were identified through microarray analysis and were validated through quantitative reverse transcription polymerase chain reaction (qRT-PCR). Survival curves were plotted using the Kaplan-Meier method and compared using the log-rank test. The circular structure of candidate circRNA was confirmed through Sanger sequencing, divergent primer PCR, and RNase R treatments. Proliferation of HCC cells was evaluated in vitro and in vivo. The microRNA (miRNA) sponge mechanism of circRNAs was demonstrated using dual-luciferase reporter and RNA immunoprecipitation assays.

Results: CircSETD3 (hsa_circRNA_0000567/hsa_circRNA_101436) was significantly downregulated in HCC tissues and cell lines. Low expression of circSETD3 in HCC tissues significantly predicted an unfavourable prognosis and was correlated with larger tumour size and poor differentiation of HCC in patients. In vitro experiments showed that circSETD3 inhibited the proliferation of HCC cells and induced G1/S arrest in HCC cells. In vivo studies revealed that circSETD3 was stably overexpressed in a xenograft mouse model and inhibited the growth of HCC. Furthermore, we demonstrated that circSETD3 acts as a sponge for miR-421 and verified that mitogen-activated protein kinase (MAPK)14 is a novel target of miR-421.

Conclusion: CircSETD3 is a novel tumour suppressor of HCC and is a valuable prognostic biomarker. Moreover, circSETD3 inhibits the growth of HCC partly through the circSETD3/miR-421/MAPK14 pathway.

Citing Articles

Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review).

Ye G, Ye M, Jin X Am J Cancer Res. 2024; 14(9):4113-4171.

PMID: 39417171 PMC: 11477829. DOI: 10.62347/UJVP4361.


CircRNA and lncRNA-encoded peptide in diseases, an update review.

Yi Q, Feng J, Lan W, Shi H, Sun W, Sun W Mol Cancer. 2024; 23(1):214.

PMID: 39343883 PMC: 11441268. DOI: 10.1186/s12943-024-02131-7.


Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development.

Aria H, Azizi M, Nazem S, Mansoori B, Darbeheshti F, Niazmand A Heliyon. 2024; 10(15):e35208.

PMID: 39170516 PMC: 11337742. DOI: 10.1016/j.heliyon.2024.e35208.


CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.

Gong J, Han G, Chen Z, Zhang Y, Xu B, Xu C J Transl Med. 2024; 22(1):517.

PMID: 38816735 PMC: 11137954. DOI: 10.1186/s12967-024-05233-4.


CircPRKD3/miR-6783-3p responds to mechanical force to facilitate the osteogenesis of stretched periodontal ligament stem cells.

Liu J, Liu R, Wang H, Zhang Z, Wang J, Wei F J Orthop Surg Res. 2024; 19(1):257.

PMID: 38649946 PMC: 11036753. DOI: 10.1186/s13018-024-04727-7.


References
1.
Kamnasaran D, Cox D . Current status of human chromosome 14. J Med Genet. 2002; 39(2):81-90. PMC: 1735028. DOI: 10.1136/jmg.39.2.81. View

2.
Omer R, Kuijsten A, Kadaru A, Kok F, Idris M, El Khidir I . Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma. Nutr Cancer. 2004; 48(1):15-21. DOI: 10.1207/s15327914nc4801_3. View

3.
Llovet J, Schwartz M, Mazzaferro V . Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005; 25(2):181-200. DOI: 10.1055/s-2005-871198. View

4.
Fleige S, Pfaffl M . RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med. 2006; 27(2-3):126-39. DOI: 10.1016/j.mam.2005.12.003. View

5.
Miranda K, Huynh T, Tay Y, Ang Y, Tam W, Thomson A . A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006; 126(6):1203-17. DOI: 10.1016/j.cell.2006.07.031. View